<code id='91EC830144'></code><style id='91EC830144'></style>
    • <acronym id='91EC830144'></acronym>
      <center id='91EC830144'><center id='91EC830144'><tfoot id='91EC830144'></tfoot></center><abbr id='91EC830144'><dir id='91EC830144'><tfoot id='91EC830144'></tfoot><noframes id='91EC830144'>

    • <optgroup id='91EC830144'><strike id='91EC830144'><sup id='91EC830144'></sup></strike><code id='91EC830144'></code></optgroup>
        1. <b id='91EC830144'><label id='91EC830144'><select id='91EC830144'><dt id='91EC830144'><span id='91EC830144'></span></dt></select></label></b><u id='91EC830144'></u>
          <i id='91EC830144'><strike id='91EC830144'><tt id='91EC830144'><pre id='91EC830144'></pre></tt></strike></i>

          entertainment

          entertainment

          author:fashion    Page View:99425

          The Senate has set its eyes on regulating insurance plans for some of the most vulnerable patients in the U.S. — the 12.5 million people eligible for both Medicare and Medicaid.

          “They’re a complex group of people with a lot of chronic conditions — mental illness, frailty, disability,” said Jose Figueroa, an internal medicine physician and health policy expert at Brigham and Women’s Hospital. Over a third of these dual-eligible beneficiaries have less than a high school education, and about 90% make less than $20,000 per year.

          advertisement

          Just around 15% of beneficiaries are eligible for both Medicare and Medicaid, but they account for a third of these programs’ spending — around $440 billion — and still don’t receive better health care, Sen. Bill Cassidy (R-La.) pointed out in a JAMA viewpoint published earlier this month. “The root cause of worse outcomes despite spending more money is a lack of coordination of care,” Cassidy wrote.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          Abortion policy in the spotlight at Republican debate
          Abortion policy in the spotlight at Republican debate

          AlexHogan/STATYou’rereadingthewebeditionofD.C.Diagnosis.Signupheretoreceivethisnewsletterinyourinbox

          read more
          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more

          Can U.S. cancer drug shortages be fixed?

          AdobeRoughlytwomillionAmericansareexpectedtoreceiveacancerdiagnosisthisyear.Somemembersofthisalready